About this event

  • Date and time Wed 27 Jan 2021 from 4:30pm to 6:00pm
  • Location Online
  • Organised by Endocrinology and Diabetes

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. It will promote understanding and communication between general practitioners, cardiologists, nephrologists and endocrinologists working together to combat heart failure and diabetes.

In this second webinar, join us to understand the newest inhibitors and receptor agonists in the treatment of diabetes put in place for cardio-renal protection.

During this webinar you will:

  • Learn how GLP-1 receptor agonists fit into cardiovascular risk management 
  • Understand the benefits of GLP-1 receptor agonists beyond glycaemic control 
  • Discover the renoprotective effects of SGLT2i

Haven't registered for part 1 and 3 yet? Sign up to them now and get part three for free. Email events@rsm.ac.uk to claim your free place:

10 x bursary places are available for this series. Please email endocrinology@rsm.ac.uk to claim your place.

A certificate of attendance and CPD certificate with 1 CPD credit(s) per webinar of this series will be issued to those joining the webinars live. Certificates of attendance for CPD will be automatically issued after 7 days, but only where a delegate watches the webinar live in its entirety. 

Join in the conversation online
Follow us on Twitter: @RoySocMed 

Tickets

Standard pricing available until 27 January 2021.

10 x bursary places are available for this series. Please email endocrinology@rsm.ac.uk to claim your place.

Member

RSM Member RSM Trainee RSM Student
£0.00 £0.00 £0.00

Non - Member

Non - Member Trainee Student
£20.00 £15.00 £15.00

Key speakers

Professor Gerry McKay

Consultant Physician and Clinical Pharmacologist

Agenda

View the programme

Welcome and introduction 

Dr Ketan Dhatariya, Consultant in Diabetes and Endocrinology and Honorary Professor of Medicine, Norfolk and Norwich University Hospitals NHS Foundation Trust and Dr Abdul Lakhdar, Consultant Endocrinologist, Barts Health NHS Trust 

GLP-1 Ras - where do they fit in cardiovascular risk management?
The multifactorial benefits of GLP-1 RAs beyond glycaemic control

Professor Gerry McKay, Consultant Physician and Clinical Pharmacologist

The renoprotecive effects of SGLT2i
Panel discussion
Close of meeting

Location

Online

More from this series:

EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 1

This 3-part webinar will explore the challenges in managing heart failure and renal disease in diabetes.

In this first webinar, experts in their field unite to address recent clinical trial results for the management of thrombosis in diabetes and discuss new practises in the management of heart failure.

Book Book
EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 3

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. 

In this final webinar, specialists unite to discuss adopting a multifactorial approach for therapeutics and whether cardiologists and nephrologists should be able to prescribe sodium glucose transporter-2 inhibitors (SGLT2i).

Book Book

*Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.